Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Sensor Technology Detects Diabetes by Breath Analysis

By LabMedica International staff writers
Posted on 02 Jul 2013
A sensor technology could significantly simplify the diagnosis and monitoring of diabetes through breath analysis alone. More...


Physicians often recognize patients with diabetes through the condition's symptoms such as their characteristic breath of acetone, an odor that increases significantly with high glucose levels.

Chemists at the University of Pittsburgh (PA, USA) used a sol-gel approach, a method for using small molecules, often on a nanoscale level, to produce solid materials. The team combined titanium dioxide with carbon nanotubes, which acted as "skewers" to hold the particles together. These nanotubes were used because they are stronger than steel and smaller than any element of silicon-based electronics.

This method, which the scientists called "titanium dioxide on a stick," effectively combined the electrical properties of the tubes with the light-illuminating powers of the titanium dioxide. They then created the sensor device by using these materials as an electrical semiconductor, measuring its electrical resistance, which is the sensor's signal. They found the sensor could be activated with light to produce an electrical charge. This prompted them to expose the nanotubes in the sensor under ultraviolet light to measure acetone vapors, which they found were lower than previously reported sensitivities.

The authors concluded that the ultrahigh sensitivity to parts per million (ppm) level of acetone vapors, fast and reversible response, together with miniature size and room temperature operation makes this nanohybrid device a promising sensing platform that could find applications in the detection of breath acetone. The development of a micro-sized low-power electronic breath acetone-sensor device could further benefit personal healthcare by serving as a convenient and low-cost diagnostic tool for diabetes or a novel and high-throughput analytical method in the clinical studies of metabolic disorders.

Alexander Star, PhD, the lead author said, “Current monitoring devices are mostly based on blood glucose analysis, so the development of alternative devices that are noninvasive, inexpensive, and provide easy-to-use breath analysis could completely change the paradigm of self-monitoring diabetes. Our measurements have excellent detection capabilities. If such a sensor could be developed and commercialized, it could transform the way patients with diabetes monitor their glucose levels." The study was published on May 21, 2013, in the Journal of the American Chemical Society.

Related Links:
University of Pittsburgh



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.